Host variations in SARS-CoV-2 infection

t: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the “Coronavirus Disease of 2019 (COVID-19)”, and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors –e.g. age, sex, race-, the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible changes can be implemented are the other questions, which are sought to be answered.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Abadom TR, Smith AD, Tempia S, Madhi SA, Cohen C et al. (2016). Risk factors associated with hospitalisation for influenzaassociated severe acute respiratory illness in South Africa: A case-population study. Vaccine 34 (46): 5649-5655. doi: 10.1016/j.vaccine.2016.09.011
Abedi V, Olulana O, Avula V, Chaudhary D, Khan A et al. (2020). Racial, economic, and health inequality and COVID-19 infection in the United States. Journal of Racial and Ethnic Health Disparities 1. Preprint MedRxiv. doi: 10.1007/s40615- 020-00833-4
Acharya D, Lee K, Lee DS, Lee YS, Moon S-S (2020). Mortality rate and predictors of mortality in hospitalized COVID-19 patients with diabetes. Healthcare (Basel, Switzerland), 8 (3): 1-8. doi: 10.3390/healthcare8030338
Ali F, Kasry A, Amin M (2021) The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant. Medicine in Drug Discovery 10: 100086. doi: 10.1016/j. medidd.2021.100086
Almerich-Silla JM, Almiñana-Pastor PJ, Boronat-Catalá M, BellotArcís C, Montiel-Company JM (2017). Socioeconomic factors and severity of periodontal disease in adults (35-44 years). A cross sectional study. Journal of Clinical and Experimental Dentistry 9 (8): e988–e994. doi: 10.4317/jced.54033
Amodio F, Caiazza M, Calabrò P, Limongelli G (2021). Genetic susceptibility to SARS-CoV-2: from the Nehandertal age to 2020. Cardiogenetics 11 (1): 28-30. doi: 10.3390/ cardiogenetics11010004
Antalis TM, Bugge TH, Wu Q (2011). Membrane-anchored serine proteases in health and disease. In Progress in Molecular Biology and Translational Science 99 (C), pp. 1–50. Elsevier B.V. doi: 10.1016/B978-0-12-385504-6.00001-4
Antony P, Vijayan R (2021). Role of SARS-CoV-2 and ACE2 variations in COVID-19, Biomedical Journal ISSN 2319-4170. doi: 10.1016/j.bj.2021.04.006
Asselta R, Paraboschi EM, Mantovani A, Duga S (2020). ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging 12 (11) 10087–10098. doi: 10.18632/aging.103415
Baena E, Shao Z, Linn DE, Glass K, Hamblen MJ et al. (2013). ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes and Development, 27 (6): 683–698. doi: 10.1101/gad.211011.112
Bansal M. (2020). Cardiovascular disease and COVID-19. Diabetes & metabolic syndrome 14 (3): 247–250. doi: 10.1016/j. dsx.2020.03.013
Batool Z, Haroon Durrani S, Tariq S (2017). Association of Abo and Rh Blood Group Types to Hepatitis B, Hepatitis C, Hiv and Syphilis Infection, A Five Year’ Experience in Healthy Blood Donors in a Tertiary Care Hospital. In Journal of Ayub Medical College, Abbottabad 29 (1): 90-92. http://www.jamc.ayubmed. edu.pk90
Bavishi C, Maddox TM, Messerli FH (2020). Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers. JAMA Cardiology 5 (7): 745–747. doi: 10.1001/ jamacardio.2020.1282
Beamer PI, Plotkin KR, Gerba CP, Sifuentes LY, Koenig DW et al. (2015). Modeling of human viruses on hands and risk of infection in an office workplace using micro-activity data. Journal of Occupational and Environmental Hygiene 12 (4): 266–275. doi: 10.1080/15459624.2014.974808
Berlin I, Thomas D, Le Faou AL, Cornuz J (2020). COVID-19 and smoking. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco 2020 (9): 1650– 1652. doi: 10.1093/ntr/ntaa059
Bertram S, Heurich A, Lavender H, Gierer S, Danisch S et al. (2012). Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts. PLoS ONE 7 (4): e35876. doi: 10.1371/journal.pone.0035876
Bojkova D, Wagner JUG, Shumliakivska M, Aslan GS, Saleem U (2020). SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. BioRxiv. doi: 10.1101/2020.06.01.127605. 2020.06.01.127605
Burrell LM, Burchill L, Dean RG, Griggs K, Patel SK et al. (2012). Chronic kidney disease: cardiac and renal angiotensinconverting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Experimental Physiology 97 (4): 477–485. doi: 10.1113/ expphysiol.2011.063156
Chaipan C, Kobasa D, Bertram S, Glowacka I, Steffen I et al. (2009). Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin. Journal of Virology 83 (7): 3200–3211. doi: 10.1128/jvi.02205-08
Chakraborty S. (2021). Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity. Biochemical and Biophysical Research Communications 538: 97–103. doi: 10.1016/j.bbrc.2021.01.035
Chan KYK, Xu MS, Ching JCY, So TMK, Lai ST et al. (2010). CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese. Human Immunology 71 (7): 702–707. doi: 10.1016/j. humimm.2010.03.006
Chen R, Liang W, Jiang M Guan W, Zhan C et al. (2020). Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest 158 (1): 97-105.
Chen Y, Shan, K, Qian W (2020). Asians do not exhibit elevated expression or unique genetic polymorphisms for ACE2, the cell-entry receptor of SARS-CoV-2. February 1–13. doi: 10.20944/preprints202002.0258.v2
Chen Y, Yu H (2018). A13091 Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors. Journal of Hypertension 36: e1. doi: 10.1097/01.hjh.0000547990.77971.18
Cheng Y, Cheng G, Chui CH, Lau FY, Chan PKS et al. (2005). ABO blood group and susceptibility to severe acute respiratory syndrome [5]. In Journal of the American Medical Association 293 (12): 1450–1451. doi: 10.1001/jama.293.12.1450-c
Cheng Z, Zhou J, To KKW, Chu H, Li, C et al. (2015). Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenza. Journal of Infectious Diseases 212 (8): 1214–1221. doi: 10.1093/infdis/ jiv246
Chiu RWK, Tang NLS, Hui DSC, Chung GTY, Chim SSC et al. (2004). ACE2 Gene Polymorphisms Do Not Affect Outcome of Severe Acute Respiratory Syndrome. Clinical Chemistry 50 (9): 1683–1686. doi: 10.1373/clinchem.2004.035436
Corley MJ, Ndhlovu LC (2020). DNA Methylation Analysis of the COVID-19 Host Cell Receptor, Angiotensin I Converting Enzyme 2 Gene (ACE2) in the Respiratory System Reveal Age and Gender Differences doi: 10.20944/ PREPRINTS202003.0295.V1
Dai X (2020). ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. European Journal of Preventive Cardiology 27 (13): 1436-1437. doi: 10.1177/2047487320922370
Darbani B (2020). The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues. Journal of Environmental Research and Public Health 17 (10): 3433. doi: 10.20944/PREPRINTS202004.0076.V1
de Groot NG, Bontrop RE (2020). COVID-19 pandemic: is a genderdefined dosage effect responsible for the high mortality rate among males? In Immunogenetics (pp. 1–3). Springer. doi: 10.1007/s00251-020-01165-7
Delanghe JR, Speeckaert MM, De Buyzere ML (2020). The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections. Clinica Chimica Acta 505: 192–193. doi: 10.1016/j.cca.2020.03.031
Delgado JM, Duro N, Rogers DM, Tkatchenko A, Pandit SA et al. (2021). Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor. Proteins: Structure, Function and Bioinformatics doi: 10.1002/prot.26086
Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z et al. (2001). Decreased ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis and Rheumatism 44 (2): 397–407. doi: 10.1002/1529-0131(200102)44:2<397::AIDANR59>3.0.CO;2-N
Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL et al. (2010). Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Medical Journal of Australia 192 (2): 84–86. doi: 10.5694/j.1326-5377.2010. tb03424.x
Devaux CA, Rolain JM, Raoult D (2020). ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. Journal of Microbiology, Immunology and Infection 53 (3): 425–435. doi: 10.1016/j.jmii.2020.04.015
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R et al. (2020). Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369: m1985-m1985.
Engin AB, Engin ED, Engin A (2020). Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking. Environmental Toxicology and Pharmacology 78: 103411. doi: 10.1016/j.etap.2020.103411
Feldman C, Anderson R (2013). Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. In Journal of Infection 67 (3): 169–184. doi: 10.1016/j.jinf.2013.05.004
Fitzgerald KA, Kagan JC (2020). Toll-like Receptors and the Control of Immunity. Cell 180 (6): 1044–1066. doi: 10.1016/j. cell.2020.02.041
FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM et al. (2008). Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: Results from a populationbased study of prostate cancer. BMC Cancer 8 (1): 1–10. doi: 10.1186/1471-2407-8-230
Gaiha SM, Cheng J, Halpern-Felsher B (2020). Association Between Youth Smoking, Electronic Cigarette Use, and Coronavirus Disease 2019. Journal of Adolescent Health doi: 10.1016/j. jadohealth.2020.07.002
Gao F, Zheng KI, Wang XB, Sun QF, Pan KH et al. (2020). Obesity Is a Risk Factor for Greater COVID-19 Severity. In Diabetes Care 43 (7): e72-e74. doi: 10.2337/dc20-0682
Ge XY, Li JL, Yang XL, Chmura AA, Zhu G et al. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503 (7477): 535–538. doi: 10.1038/ nature12711
Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G et al. (2020). COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? International Journal of Molecular Sciences 21 (10): 1–23. doi: 10.3390/ijms21103474
Genomewide Association Study of Severe Covid-19 with Respiratory Failure (2020). New England Journal of Medicine 383 (16): 1522–1534. doi: 10.1056/nejmoa2020283
Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC et al. (2020). Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circulation Research 126 (10): 1456–1474. doi: 10.1161/ CIRCRESAHA.120.317015
Gibson W, Evans D, An J, Jones SJ (2020). ACE 2 Coding Variants: A Potential X-linked Risk Factor for COVID-19 Disease. BioRxiv 2020.04.05.026633. doi: 10.1101/2020.04.05.026633
Giri VN, Ruth K, Hughes L, Uzzo RG, Chen DYT et al. (2011). Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: Effect of TMPRSS2 Met160Val. BJU International 107 (3): 466–470. doi: 10.1111/j.1464-410X.2010.09522.x
Gralinski E, Menachery VD, Morgan AP, Totura AL, Beall A et al. (2017). Allelic variation in the toll-like receptor adaptor protein Ticam2 contributes to SARS-coronavirus pathogenesis in mice. G3: Genes, Genomes, Genetics 7 (6): 1653–1663. doi: 10.1534/g3.117.041434
Greulich W, Wagner M, Gaidt MM, Stafford C, Cheng Y et al. (2019). TLR8 Is a Sensor of RNase T2 Degradation Products. Cell 179 (6): 1264-1275.e13. doi: 10.1016/j.cell.2019.11.001
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD et al. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status. In Military Medical Research 7 (1): 1–10. BioMed Central Ltd. doi: 10.1186/s40779-020-00240-0
Hatesuer B, Bertram S, Mehnert N, Bahgat MM, Nelson PS et al. (2013). Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice. PLoS Pathogens 9 (12): e1003774. doi: 10.1371/journal.ppat.1003774
Hoffmann M, Kleine-Weber H, Krueger N, Mueller MA, Drosten C et al. (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. In bioRxiv (p. 2020.01.31.929042). Cold Spring Harbor Laboratory. BioRxiv preprint. doi: 10.1101/2020.01.31.929042
Hoffmann M, Kleine-Weber H, Schroeder S, Mueller MA, Drosten C et al. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181: 271-280.e8. doi: 10.1016/j.cell.2020.02.052
Hu H, Ma F, Wei X, Fang Y (2020). Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. European Heart Journal 42 (2): 206. doi: 10.1093/eurheartj/ ehaa248. ehaa190
Huang C, Wang Y, Li X, Ren L, Zhao J et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395 (10223): 497–506. doi: 10.1016/S0140- 6736(20)30183-5
Hussain M, Jabeen N, Raza F, Shabbir S, Baig AA et al. (2020). Structural Variations in Human ACE2 may Influence its Binding with SARS-CoV-2 Spike Protein. Journal of Medical Virology March. doi: 10.1002/jmv.25832
Jackson SE, Brown J, Shahab L, Steptoe A, Fancourt D (2020). COVID-19, smoking and inequalities: a study of 53 002 adults in the UK. Tobacco Control tobaccocontrol-2020-055933. doi: 10.1136/tobaccocontrol-2020-055933
Jernigan DB, Cox NJ (2015). H7N9: Preparing for the unexpected in influenza. Annual Review of Medicine 66: 361–371. doi: 10.1146/annurev-med-010714-112311
Jin J-M, Bai P, He W, Wu F, Liu X-F et al. (2020). Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in Public Health 8: 152. doi: 10.3389/ fpubh.2020.00152
Johansson MU, Zoete V, Michielin O, Guex N (2012). Defining and searching for structural motifs using DeepView/SwissPdbViewer. Ka L, Hospital M, Lai ST, So KM, Khoo U-S et al. (2009). Research fund for the control of ınfectıous dıseases Functional role of ICAM-3 polymorphism in genetic susceptibility to SARS infection Key Messages. In Hong Kong Medical Journal 15 (5): 26-29.
Kabesch M, Hasemann K, Schickinger V, Tzotcheva I, Bohnert A et al. (2004). A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy 59 (5): 520–525. doi: 10.1111/j.1398- 9995.2004.00439.x
Kaidarova Z, Bravo MD, Kamel HT, Custer BS, Busch MP et al. (2016). Blood group A and D negativity are associated with symptomatic West Nile virus infection. Transfusion 56 (7): 1699–1706. doi: 10.1111/trf.13622
Kara C, Çelen K, Dede FÖ, Gökmenoğlu C, Kara NB (2020). Is periodontal disease a risk factor for developing severe Covid-19 infection? The potential role of Galectin-3. Experimental Biology and Medicine 245 (16): 1425-2427. doi: 10.1177/1535370220953771
Khatri I, Staal FJT, van Dongen Jacques JM (2020) Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective. Frontiers in Immunology 11: 2258. doi: 10.3389/fimmu.2020.570018
Kim TS, Heinlein C, Hackman RC, Nelson PS (2006). Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease. Molecular and Cellular Biology 26 (3): 965–975. doi: 10.1128/ mcb.26.3.965-975.2006
Klein SL, Flanagan KL (2016). Sex differences in immune responses. In Nature Reviews Immunology 16 (10): 626–638. Nature Publishing Group. doi: 10.1038/nri.2016.90
Lam TTY, Jia N, Zhang YW Shum MHH, Jiang JF et al. (2020). Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature 583: 282–285. doi: 10.1038/s41586-020- 2169-0
Lan J, Ge J, Yu J, Shan S, Zhou H et al. (2020). Structure of the SARSCoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581 (7807): 215–220. doi: 10.1038/s41586- 020-2180-5
Lassale C, Gaye B, Hamer M, Gale CR, Batty GD (2020). Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study. Brain, Behavior, and Immunity 88: 44–49. doi: 10.1016/j. bbi.2020.05.074
Leung TF, Tang NLS, Wong GWK, Fok, TF (2005). CD14 and toll-like receptors: Potential contribution of genetic factors and mechanisms to inflammation and allergy. In Current Drug Targets: Inflammation and Allergy 4 (2): 169–175. doi: 10.2174/1568010053586336
Li F (2015). Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies. Journal of Virology 89 (4): 1954– 1964. doi: 10.1128/jvi.02615-14
Li M, Li L, Zhang Y, Wang X (2020). An Investigation of the Expression of 2019 Novel Coronavirus Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues. doi: 10.21203/ rs.2.24751/v1
Li MY, Li L, Zhang Y, Wang XS (2020). Expression of the SARSCoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty 9 (1): 45. doi: 10.1186/ s40249-020-00662-x
Li Q, Cao Z, Rahman P (2020). Genetic Variability of Human Angiotensin-Converting Enzyme 2 (hACE2) Among Various Ethnic Populations. Molecular Genetics & Genomic Medicine 2020.04.14.041434. doi: 10.1101/2020.04.14.041434
Li Y, Gorelik G, Strickland FM, Richardson BC (2014). Oxidative stress, t cell dna methylation, and lupus. Arthritis and Rheumatology 66 (6): 1574–1582. doi: 10.1002/art.38427
Li X, Xu S, Yu M, Wang K, Tao Y et al. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. The Journal of Allergy and Clinical Immunology 146 (1): 110-118.
Liao Y, Xue L, Gao J, Wu A, Kou X (2020). ABO blood groupassociated susceptibility to norovirus infection: A systematic review and meta-analysis. Infection, Genetics and Evolution 81: 104245. doi: 10.1016/j.meegid.2020.104245
Lighter J, Phillips M, Hochman S, Sterling S, Johnson D et al. (2020). Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. In Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 71 (15): 896–897. NLM (Medline). doi: 10.1093/cid/ ciaa415
Lim KH, Staudt LM (2013). Toll-Like receptor signaling. Cold Spring Harbor Perspectives in Biology 5 (1): a011247. doi: 10.1101/ cshperspect.a011247
Lippi G, Henry BM (2020). Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). In European Journal of Internal Medicine 75: 107–108. Elsevier B.V. doi: 10.1016/j.ejim.2020.03.014
Liu J, Ji H, Zheng W, Wu X, Zhu JJ et al. (2010). Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent. Biology of Sex Differences 1 (1): 6. doi: 10.1186/2042-6410-1-6
Lucas JM, True L, Hawley S, Matsumura M, Morrissey C et al. (2008). The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. Journal of Pathology 215 (2): 118–125. doi: 10.1002/path.2330
Mahla RS, Reddy MC, Vijaya Raghava Prasad D, Kumar H (2013). Sweeten PAMPs: Role of sugar complexed PAMPs in innate immunity and vaccine biology. In Frontiers in Immunology 4: 248. Frontiers. doi: 10.3389/fimmu.2013.00248
McKelvey K, Halpern-Felsher B (2020). How and Why California Young Adults Are Using Different Brands of Pod-Type Electronic Cigarettes in 2019: Implications for Researchers and Regulators. Journal of Adolescent Health 67 (1): 46–52. doi: 10.1016/j.jadohealth.2020.01.017
Menachery VD, Yount BL, Josset L, Gralinski LE, Scobey T et al. (2014). Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2’-O-Methyltransferase Activity. Journal of Virology 88 (8): 4251–4264. doi: 10.1128/jvi.03571-13
Mendy A, Keller JL, Apewokin S, Morrow AL (2020). Is Blood Type Associated with COVID-19 Severity? MedRxiv : The Preprint Server for Health Sciences 1–11. doi: 10.1101/2020.08.11.20172676
Mikkonen L, Pihlajamaa P, Sahu B, Zhang FP, Jänne OA (2010). Androgen receptor and androgen-dependent gene expression in lung. Molecular and Cellular Endocrinology 317 (1–2): 14– 24. doi: 10.1016/j.mce.2009.12.022
Mortazavi SAR, Kaveh-Ahangar K, Mortazavi SMJ, Firoozi D, Haghani M (2021). How our neanderthal genes affect the COVID-19 mortality: Iran and mongolia, two countries with the same SARSCoV-2 mutation cluster but different mortality rates. Journal of Biomedical Physics and Engineering 11 (1): 109–114. doi: 10.31661/jbpe.v0i0.2010-1218
Newton K, Dixit VM (2012). Signaling in innate immunity and inflammation. Cold Spring Harbor Perspectives in Biology 4 (3): a006049. doi: 10.1101/cshperspect.a006049
O’Driscoll M, Ribeiro Dos Santos G, Wang L Cummings DAT et al. (2021). Age-specific mortality and immunity patterns of SARSCoV-2. Nature 590: 140–145 doi: 10.1038/s41586-020-2918-0
Ortiz-Fernández L, Sawalha AH (2020). Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations. Genes & Immunity 1–4. doi: 10.1038/s41435- 020-0107-7
Othman H, Bouslama Z, Brandenburg J-T, Rocha J da Hamdi, Y, Ghedira K et al. (2020). In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARSCoV, hot-spot analysis and effect of the receptor polymorphism. BioRxiv 2. 2020.03.04.976027. doi: 10.1101/2020.03.04.976027
Ou X, Liu Y, Lei X, Li P, Mi D et al. (2020). Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications 11 (1). doi: 10.1038/s41467-020-15562-9
Patanavanich R, Glantz SA (2020). Smoking is Associated with COVID-19 Progression: A Meta-Analysis. Nicotine & Tobacco Research, 2020 (9): 1653–1656. doi: 10.1093/ntr/ntaa082
Perlman S, Netland J (2009). Coronaviruses post-SARS: Update on replication and pathogenesis. In Nature Reviews Microbiology 7 (5): 439–450. Nature Publishing Group. doi: 10.1038/ nrmicro2147
Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC et al. (2013). Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2: ERG. JNCI: Journal of the National Cancer Institute 105 (24): 1881–1890. doi: 10.1093/ jnci/djt332
Pinheiro DS, Santos RS, Veiga Jardim PCB, Silva EG, Reis AAS et al. (2019). The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients. PLoS ONE 14 (8). doi: 10.1371/journal.pone.0221248
Raisi-Estabragh Z, McCracken C, Bethell MS, Cooper J, Cooper C et al. (2020). Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank. Journal of Public Health, 42 (3): 451–460. doi: 10.1093/pubmed/fdaa095
Ramanathan M, Ferguson ID, Miao W, Khavari PA. (2021). SARSCoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. Lancet Infect Dis. 2021 May 19. doi: 10.1016/S1473-3099(21)00262-0. Epub ahead of print. PMID: 34022142; PMCID: PMC8133765.
Rawat P, Jemimah S, Ponnuswamy PK, Gromiha MM (20217). Why are ACE2 binding coronavirus strains SARS-CoV/SARSCoV-2 wild and NL63 mild? Proteins. 2021 (89): 389– 398. doi: 10.1002/prot.26024
Reinikovaite V, Rodriguez IE, Karoor V, Rau A, Trinh BB, Deleyiannis FWB, Taraseviciene-Stewart L (2018). The effects of electronic cigarette vapour on the lung: Direct comparison to tobacco smoke. In European Respiratory Journal 51 (4). European Respiratory Society. doi: 10.1183/13993003.01661-2017
Renauer PA, Coit P, Sawalha AH (2015). The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clinical Immunology 156 (1): 19–27. doi: 10.1016/j.clim.2014.10.007
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323(20):2052-2059.
Rossi GA, Sacco O, Mancino E, Cristiani L Midulla F (2020). Differences and similarities between SARS-CoV and SARSCoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. Infection 48: 665–669 doi: 10.1007/s15010-020-01486-5
Sardu C, Marfella R, Maggi P, Messina V, Cirillo P et al. (2020). Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovascular Disorders 20 (1): 1–10. doi: 10.1186/s12872-020-01658-z
Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F (2020a). Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America, 117 (21): 11727–11734. doi: 10.1073/pnas.2003138117
Shang J, Ye G, Shi K, Wan Y, Luo C (2020b). Structural basis of receptor recognition by SARS-CoV-2. Nature 581: 221–224. doi: 10.1038/s41586-020-2179-y
Shang L, Qi Y, Bao QY, Tian W, Xu JC et al. (2006). Polymorphism of SARS-CoV genomes. Acta Genetica Sinica, 33 (4): 354–364. doi: 10.1016/S0379-4172(06)60061-9
Schuler BA, Christian Habermann A, Plosa EJ, Taylor CJ, Jetter C et al. (2020). Age-related expression of SARS-CoV-2 priming protease TMPRSS2 in the developing lung. bioRxiv : The Preprint Server for Biology 2020.05.22.111187. doi: 10.1101/2020.05.22.111187
Silver V, Chapple AG, Feibus AH, Beckford J, Halapin NA et al. (2020). Clinical Characteristics and Outcomes Based on Race of Hospitalized Patients with COVID-19 in a New Orleans Cohort. Open Forum Infectious Diseases 7 (9). doi: 10.1093/ ofid/ofaa339
Simons D, Shahab L, Brown J, Perski O (2020). The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7). Qeios. doi: 10.32388/ UJR2AW.8
Souyris M, Cenac C, Azar P, Daviaud D, Canivet A et al. (2018). TLR7 escapes X chromosome inactivation in immune cells. Science Immunology 3 (19). doi: 10.1126/sciimmunol.aap8855
Stelzig KE, Canepa-Escaro F, Schiliro M, Berdnikovs S, Prakash YS et al. (2020). Estrogen regulates the expression of SARSCoV-2 receptor ACE2 in differentiated airway epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology. 318: L1280-L1281. doi: 10.1152/ ajplung.00153.2020
Stopsack KH, Mucci LA, Mph S, Antonarakis ES, Nelson PS et al. (2020). TMPRSS2 and COVID-19 : Serendipity or opportunity for intervention? 10 (6): 779-782. doi: 10.1158/2159-8290.CD20-0451
Suryamohan K, Diwanji D, Stawiski EW, Gupta R, Miersch S et al. (2021). Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Communications Biology, 4 (1): 1–11. doi: 10.1038/s42003-021-02030-3
Tanigawa Y, Rivas MA (2020). Initial review and analysis of COVID-19 host genetics and associated phenotypes. Preprints, March, 1–19. doi: 10.20944/preprints202003.0356.v1
Totura AL, Baric RS (2012). SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon. In Current Opinion in Virology 2 (3): 264–275. doi: 10.1016/j. coviro.2012.04.004
Totura AL, Whitmore A, Agnihothram S, Schäfer A, Katze MG et al. (2015). Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. MBio 6 (3): 1–14. doi: 10.1128/mBio.00638-15
Usman MS, Siddiqi TJ, Khan MS, Patel UK, Shahid I et al. (2020). Is there a smoker’s paradox in COVID-19? BMJ EvidenceBased Medicine bmjebm-2020-111492. doi: 10.1136/ bmjebm-2020-111492
Vangjeli C, Dicker P, Tregouet DA, Shields DC, Evans A et al. (2011). A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: The MORGAM project. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System 12 (4): 504–509. doi: 10.1177/1470320311405557
Vardavas CI, Nikitara K (2020). COVID-19 and smoking: A systematic review of the evidence. In Tobacco Induced Diseases (Vol. 18, Issue March). International Society for the Prevention of Tobacco Induced Diseases doi: 10.18332/tid/119324
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT et al. (2020). Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181 (2): 281-292.e6. doi: 10.1016/j. cell.2020.02.058
Wan Y, Shang J, Graham R, Baric RS, Li F (2020). Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology 94 (7). doi: 10.1128/jvi.00127-20
Wang CH, Eng HL, Lin KH, Chang CH, Hsieh CA et al. (2011). TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS ONE 6 (10): e26235. doi: 10.1371/ journal.pone.0026235
Wang CM, Chang SW, Wu YJJ, Lin JC, Ho HH et al. (2014). Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Scientific Reports 4. doi: 10.1038/srep03792
Wang S, Wei M, Han Y, Zhang K, He L et al. (2008). Roles of TNFalpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study. BMC Infectious Diseases 8: 27. doi: 10.1186/1471-2334-8-27
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C et al. (2020). Factors associated with COVID-19-related death using OpenSAFELY. Nature 584 (7821): 430–436. doi: 10.1038/ s41586-020-2521-4
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L et al. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367 (6483): 1260–1263. doi: 10.1126/science.abb2507
Wu BB, Gu DZ, Yu JN, Yang J, Shen WQ (2020). Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis. Infection, genetics and evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 84: 104485.
Xia S, Liu M, Wang C, Xu W, Lan Q et al. (2020). Inhibition of SARSCoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Research 30: 343–355. doi: 10.1038/s41422-020-0305-x
Yan R, Zhang Y, Li Y, Xia L, Guo Y et al. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.
Science 367 (6485): 1444–1448. doi: 10.1126/science.abb2762 Yan T, Xiao R, Lin G (2020). Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARSCoV-2: A double-edged sword? FASEB Journal 34 (5): 6017– 6026. doi: 10.1096/fj.202000782
Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC et al. (2020). Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nature Communications 11: 4541. doi: 10.1038/s41467-020-18319-6
Yang W, Huang W, Su S, Li B, Zhao W et al. (2006). Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. Clinical Science 111 (5): 333–340. doi: 10.1042/CS20060020
Yuan FF, Boehm I, Chan PKS, Marks K, Tang JW et al. (2007). High Prevalence of the CD14-159CC Genotype in Patients Infected with Severe Acute Respiratory Syndrome-Associated Coronavirus. Clınıcal and Vaccıne Immunology 14 (12): 1644– 1645. doi: 10.1128/CVI.00100-07
Zeberg H, Pääbo S (2020). The major genetic risk factor for severe COVID-19 is inherited from Neandertals Authors. BioRxiv 2020.07.03.186296. doi: 10.1101/2020.07.03.186296
Zeberg H, Pääbo S (2021). A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Proceedings of the National Academy of Sciences of the United States of America 118 (9). doi: 10.1073/ pnas.2026309118
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y et al. (2020) Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. American Journal Respiratory Critical Care Medicine 202: 756-759. doi: 10.1164/rccm.202001-0179LE
Zhao J, Yang Y, Huang H-P, Li D, Gu D-F et al. (2020). Relationship between the ABO Blood Group and the COVID-19 Susceptibility. MedRxiv 2020.03.11.20031096. doi: 10.1101/2020.03.11.20031096
Zhao M, Liu S, Luo S, Wu H, Tang M et al. (2014). DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. Journal of Autoimmunity 54: 127–136. doi: 10.1016/j.jaut.2014.07.002
Zhou F, Yu T, Du R, Fan G, Liu Y et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395 (10229): 1054-1062.
Zhou P, Yang X, Lou Wang XG, Hu B, Zhang L et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (7798): 270–273. doi: 10.1038/ s41586-020-2012-7
Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA et al. (2020). Obesity & genetic predisposition with COVID-19. Metabolism 154345. doi: 10.1016/j.metabol.2020.154345
Zietz M, Zucker J, Tatonetti N (2020). Testing the association between blood type and COVID-19 infection, intubation, and death. MedRxiv : The Preprint Server for Health Sciences 2020.04.08.20058073. doi: 10.1101/2020.04.08.20058073

APA	Altıok D, Savcı E, Özkara B, Alkan K, Namdar D, Tunçer G, Kılınç B, suiçmez e, Çetin G, Ünal S, Dönmüş B, Karagülleoğlu Z, uncuoğlu d, Tekeli C, mendi a, Bengi V, Cengiz Seval G, Kilic P, Gunes Altuntas E, Demir Dora D (2021). Host variations in SARS-CoV-2 infection. , 404 - 424. 10.3906/biy-2104-67
Chicago	Altıok Doruk,Savcı Elif Zeynep,Özkara Büşra,Alkan Kamil,Namdar Dilara Sultan,Tunçer Gizem,Kılınç Buğrahan Regaip,suiçmez evren,Çetin Güneysu,Ünal Sinan,Dönmüş Beyza,Karagülleoğlu Zeynep Yağmur,uncuoğlu dilruba beyza,Tekeli Cansu,mendi aysegul,Bengi Vahdi Umut,Cengiz Seval Guldane,Kilic Pelin,Gunes Altuntas Evrim,Demir Dora Devrim Host variations in SARS-CoV-2 infection. (2021): 404 - 424. 10.3906/biy-2104-67
MLA	Altıok Doruk,Savcı Elif Zeynep,Özkara Büşra,Alkan Kamil,Namdar Dilara Sultan,Tunçer Gizem,Kılınç Buğrahan Regaip,suiçmez evren,Çetin Güneysu,Ünal Sinan,Dönmüş Beyza,Karagülleoğlu Zeynep Yağmur,uncuoğlu dilruba beyza,Tekeli Cansu,mendi aysegul,Bengi Vahdi Umut,Cengiz Seval Guldane,Kilic Pelin,Gunes Altuntas Evrim,Demir Dora Devrim Host variations in SARS-CoV-2 infection. , 2021, ss.404 - 424. 10.3906/biy-2104-67
AMA	Altıok D,Savcı E,Özkara B,Alkan K,Namdar D,Tunçer G,Kılınç B,suiçmez e,Çetin G,Ünal S,Dönmüş B,Karagülleoğlu Z,uncuoğlu d,Tekeli C,mendi a,Bengi V,Cengiz Seval G,Kilic P,Gunes Altuntas E,Demir Dora D Host variations in SARS-CoV-2 infection. . 2021; 404 - 424. 10.3906/biy-2104-67
Vancouver	Altıok D,Savcı E,Özkara B,Alkan K,Namdar D,Tunçer G,Kılınç B,suiçmez e,Çetin G,Ünal S,Dönmüş B,Karagülleoğlu Z,uncuoğlu d,Tekeli C,mendi a,Bengi V,Cengiz Seval G,Kilic P,Gunes Altuntas E,Demir Dora D Host variations in SARS-CoV-2 infection. . 2021; 404 - 424. 10.3906/biy-2104-67
IEEE	Altıok D,Savcı E,Özkara B,Alkan K,Namdar D,Tunçer G,Kılınç B,suiçmez e,Çetin G,Ünal S,Dönmüş B,Karagülleoğlu Z,uncuoğlu d,Tekeli C,mendi a,Bengi V,Cengiz Seval G,Kilic P,Gunes Altuntas E,Demir Dora D "Host variations in SARS-CoV-2 infection." , ss.404 - 424, 2021. 10.3906/biy-2104-67
ISNAD	Altıok, Doruk vd. "Host variations in SARS-CoV-2 infection". (2021), 404-424. https://doi.org/10.3906/biy-2104-67

APA	Altıok D, Savcı E, Özkara B, Alkan K, Namdar D, Tunçer G, Kılınç B, suiçmez e, Çetin G, Ünal S, Dönmüş B, Karagülleoğlu Z, uncuoğlu d, Tekeli C, mendi a, Bengi V, Cengiz Seval G, Kilic P, Gunes Altuntas E, Demir Dora D (2021). Host variations in SARS-CoV-2 infection. Turkish Journal of Biology, 45(4), 404 - 424. 10.3906/biy-2104-67
Chicago	Altıok Doruk,Savcı Elif Zeynep,Özkara Büşra,Alkan Kamil,Namdar Dilara Sultan,Tunçer Gizem,Kılınç Buğrahan Regaip,suiçmez evren,Çetin Güneysu,Ünal Sinan,Dönmüş Beyza,Karagülleoğlu Zeynep Yağmur,uncuoğlu dilruba beyza,Tekeli Cansu,mendi aysegul,Bengi Vahdi Umut,Cengiz Seval Guldane,Kilic Pelin,Gunes Altuntas Evrim,Demir Dora Devrim Host variations in SARS-CoV-2 infection. Turkish Journal of Biology 45, no.4 (2021): 404 - 424. 10.3906/biy-2104-67
MLA	Altıok Doruk,Savcı Elif Zeynep,Özkara Büşra,Alkan Kamil,Namdar Dilara Sultan,Tunçer Gizem,Kılınç Buğrahan Regaip,suiçmez evren,Çetin Güneysu,Ünal Sinan,Dönmüş Beyza,Karagülleoğlu Zeynep Yağmur,uncuoğlu dilruba beyza,Tekeli Cansu,mendi aysegul,Bengi Vahdi Umut,Cengiz Seval Guldane,Kilic Pelin,Gunes Altuntas Evrim,Demir Dora Devrim Host variations in SARS-CoV-2 infection. Turkish Journal of Biology, vol.45, no.4, 2021, ss.404 - 424. 10.3906/biy-2104-67
AMA	Altıok D,Savcı E,Özkara B,Alkan K,Namdar D,Tunçer G,Kılınç B,suiçmez e,Çetin G,Ünal S,Dönmüş B,Karagülleoğlu Z,uncuoğlu d,Tekeli C,mendi a,Bengi V,Cengiz Seval G,Kilic P,Gunes Altuntas E,Demir Dora D Host variations in SARS-CoV-2 infection. Turkish Journal of Biology. 2021; 45(4): 404 - 424. 10.3906/biy-2104-67
Vancouver	Altıok D,Savcı E,Özkara B,Alkan K,Namdar D,Tunçer G,Kılınç B,suiçmez e,Çetin G,Ünal S,Dönmüş B,Karagülleoğlu Z,uncuoğlu d,Tekeli C,mendi a,Bengi V,Cengiz Seval G,Kilic P,Gunes Altuntas E,Demir Dora D Host variations in SARS-CoV-2 infection. Turkish Journal of Biology. 2021; 45(4): 404 - 424. 10.3906/biy-2104-67
IEEE	Altıok D,Savcı E,Özkara B,Alkan K,Namdar D,Tunçer G,Kılınç B,suiçmez e,Çetin G,Ünal S,Dönmüş B,Karagülleoğlu Z,uncuoğlu d,Tekeli C,mendi a,Bengi V,Cengiz Seval G,Kilic P,Gunes Altuntas E,Demir Dora D "Host variations in SARS-CoV-2 infection." Turkish Journal of Biology, 45, ss.404 - 424, 2021. 10.3906/biy-2104-67
ISNAD	Altıok, Doruk vd. "Host variations in SARS-CoV-2 infection". Turkish Journal of Biology 45/4 (2021), 404-424. https://doi.org/10.3906/biy-2104-67